Drug recall · August 26, 2026
niCARdipine Hydrochloride Injection recall
Why: Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
niCARdipine Hydrochloride Injection, USP, 25 mg/10mL (2.5 mg/mL), packaged in a) 10 mL Single Dose Vial (NDC 72572-470-01) and b) 10x10 mL Single Dose Vials (NDC 72572-470-10), Rx Only, Mfd for: Civica, Inc., Lehi, UT, Mfd by: American Regent, Inc., New Albany, OH 43054.
- Lots / codes
Lot #: 25295N0C0, Exp. Date: 04/30/2027.
- Quantity
- 43,460 vials
- Company
- American Regent, Inc., Shirley, NY
- Distribution
- Nationwide within the U.S
- Initiated
- July 24, 2026 · Voluntary: Firm initiated
- Classified
- August 26, 2026
- Reported
- August 26, 2026
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nicardipine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.